US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
You may also like
Gainers
Latest Crypto News
The Wise Investor invested $179,800 in PIPPIN one month ago, and now has an unrealized gain of $1,350,000.
「HYPE Listing Insider Whale」's 5x HYPE Long Position is currently at a $10.87 million unrealized loss
Opinion: While the current round of quantitative tightening in the U.S. is set to conclude today, its related effects may not be felt until early next year
Rayls Tokenomics Release: TGE to Distribute 15% of Tokens
Japan's 2-Year Government Bond Yield Rises to 1%, Hits New High Since 2008
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]